Novo Nordisk has won a Committee for Medicinal Products for Human Use (CHMP) endorsement for a higher-dose version of its diabetes drug liraglutide that can be used to treat obesity. The Danish ...

Saxenda, like Ozempic and Wegovy, is a GLP-1 receptor agonist, but it’s made with liraglutide (instead of semaglutide). The medication is also prescription-only and FDA-approved for the ...

Also Read: Novo Nordisk’s Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Lexaria Bioscience (LEXX) it has received the necessary independent ethics board approval required for its contract research organization to ...

Marketed as Ozempic, Wegovy or Saxenda, these drugs are administered via a weekly injection that mimics GLP-1 - a hormone that helps regulate hunger and slow digestion. It is only available with a ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...